Zobrazeno 1 - 10
of 403
pro vyhledávání: '"Jean-Claude Reubi"'
Autor:
Adrian F Daly, Liliya Rostomyan, Daniela Betea, Jean-François Bonneville, Chiara Villa, Natalia S Pellegata, Beatrice Waser, Jean-Claude Reubi, Catherine Waeber Stephan, Emanuel Christ, Albert Beckers
Publikováno v:
Endocrine Connections, Vol 8, Iss 4, Pp 367-377 (2019)
Acromegaly is a rare disease due to chronic excess growth hormone (GH) and IGF-1. Aryl hydrocarbon receptor interacting protein (AIP) mutations are associated with an aggressive, inheritable form of acromegaly that responds poorly to SST2-specific so
Externí odkaz:
https://doaj.org/article/99d6a84e6ca34e03ae4397339330bbfb
Autor:
Matthias Hepprich, Kwadwo Antwi, Beatrice Waser, Jean Claude Reubi, Damian Wild, Emanuel R. Christ
Publikováno v:
Case Reports in Endocrinology, Vol 2020 (2020)
Severe cases of postprandial hypoglycaemia after bariatric surgery can be a diagnostic and therapeutic challenge. The diagnostic role of 68Ga-DOTA-Exendin-4 PET/CT in postbariatric hypoglycaemia for further treatment decisions is unclear. We present
Externí odkaz:
https://doaj.org/article/77135ff9bafd457a81d29bd492b1f897
Autor:
Hans-Jürgen Wester, Annamaria Vezzani, Giovanni Tulipano, John E. Taylor, Stefan Schulz, Agnes Schonbrunn, Herbert Schmid, Marcus Schindler, Jean-Claude Reubi, Terry Reisine, Yogesh C. Patel, Anne-Marie O'Carroll, Wolfgang Meyerhof, Shlomo Melmed, Amelie Lupp, Hans-Jürgen Kreienkamp, Patrick P. A. Humphrey, Daniel Hoyer, Leo Hofland, Rebecca Hills, Anthony Harmar, Wasyl Feniuk, Jacques Epelbaum, Pascal Dournaud, Micheal Culler, Zsolt Csaba, Justo P. Castaño, Corinne Bosquet
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2023
Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [98]). Activation of th
Autor:
Helmut R. Maecke, Jean Claude Reubi, Renzo Cescato, Beatrice Waser, Maria-Luisa Tamma, Stefan Kneifel, Flavio Forrer, Xuejuan Wang, Rosalba Mansi
Supplementary Data from Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid–Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9087d798b8f816e6ecb1b526cf39e429
https://doi.org/10.1158/1078-0432.22440334
https://doi.org/10.1158/1078-0432.22440334
Autor:
Helmut R. Maecke, Jean-Claude Reubi, Anne Provencher-Bolliger, Julie Boisclair, Frank Bruchertseifer, Alfred Morgenstern, Hanwen Zhang, Michael Frischknecht, Damian Wild
Supplementary Table 1 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34939e7f3f9378a6028445e14bd1048b
https://doi.org/10.1158/0008-5472.22387452.v1
https://doi.org/10.1158/0008-5472.22387452.v1
Autor:
Helmut R. Maecke, Jean-Claude Reubi, Anne Provencher-Bolliger, Julie Boisclair, Frank Bruchertseifer, Alfred Morgenstern, Hanwen Zhang, Michael Frischknecht, Damian Wild
Supplementary Table 3 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32895aeb32a667c785ce4c6c92c4bc18
https://doi.org/10.1158/0008-5472.22387446
https://doi.org/10.1158/0008-5472.22387446
Autor:
Helmut R. Maecke, Jean-Claude Reubi, Anne Provencher-Bolliger, Julie Boisclair, Frank Bruchertseifer, Alfred Morgenstern, Hanwen Zhang, Michael Frischknecht, Damian Wild
Supplementary Figures 1-4 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52085c316efb4106efb5861c48a46f85
https://doi.org/10.1158/0008-5472.22387455.v1
https://doi.org/10.1158/0008-5472.22387455.v1
Autor:
Helmut R. Maecke, Jean-Claude Reubi, Anne Provencher-Bolliger, Julie Boisclair, Frank Bruchertseifer, Alfred Morgenstern, Hanwen Zhang, Michael Frischknecht, Damian Wild
Supplementary Table 2 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10cbc61e69ed4c239d2da6455e9e72e2
https://doi.org/10.1158/0008-5472.22387449.v1
https://doi.org/10.1158/0008-5472.22387449.v1
Autor:
Jean Claude Reubi, Damian Wild, Kwadwo Antwi, Beatrice Waser, Stefanie Schwanda, Aurel Perren, Christoph Schmid, Hans Ulrich Baer, Tobias Heye, Emanuel Christ, Melpomeni Fani
Publikováno v:
Christ, Emanuel; Wild, Damian; Antwi, Kwadwo; Waser, Beatrice; Fani, Melpomeni; Schwanda, Stefanie; Heye, Tobias; Schmid, Christoph; Baer, Hans Ulrich; Perren, Aurel; Reubi, Jean Claude (2015). Preoperative localization of adult nesidioblastosis using (68)Ga-DOTA-exendin-4-PET/CT. Endocrine, 50(3), pp. 821-823. Springer 10.1007/s12020-015-0633-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7858ababbc8755a3af54ef8d73fedb78
http://doc.rero.ch/record/331999/files/12020_2015_Article_633.pdf
http://doc.rero.ch/record/331999/files/12020_2015_Article_633.pdf
Autor:
Emanuel Christ, François Pattou, Beat Gloor, Aurel Perren, Damian Wild, Jean Claude Reubi, Ashley B. Grossman, Deborah R. Vogt, Philippe Chanson, Kwadwo Antwi, Tobias Heye, Melpomeni Fani, Guillaume Nicolas
Publikováno v:
Antwi, Kwadwo; Nicolas, Guillaume; Fani, Melpomeni; Heye, Tobias; Pattou, Francois; Grossman, Ashley; Chanson, Philippe; Reubi, Jean Claude; Perren, Aurel; Gloor, Beat; Vogt, Deborah R; Wild, Damian; Christ, Emanuel (2019). 68Ga-exendin-4 PET/CT detects insulinomas in patients with endogenous hyperinsulinemic hypoglycemia in MEN-1. The journal of clinical endocrinology and metabolism, 104(12), pp. 5843-5852. Oxford University Press 10.1210/jc.2018-02754
Context Surgical intervention is advised in patients with multiple endocrine neoplasia type-1 (MEN-1) and nonfunctioning pancreatic neuroendocrine tumors (PanNETs) with a size ≥20 mm. Functioning PanNETs, such as in patients with endogenous hyperin